RTW Biotech Opportunities Ltd

Overview

RTW Biotech Opportunities Ltd is a London Stock Exchange-listed investment trust focusing on biotechnology investments. The company aims to identify transformative assets with high growth potential across the life sciences sector, applying deep scientific expertise with a long-term investment horizon. It invests in companies developing innovative medical therapies for diseases with limited treatment options. The investment strategy involves full lifecycle investing, supporting scientists and entrepreneurs at any stage where opportunities are identified, from academic programs in need of industry sponsorship to mature publicly traded companies. The company seeks to maximize value realization from transformative products over time, being involved and invested in such companies throughout various stages of their development and delivery to patients. As of 31 January 2026, RTW Biotech Opportunities Ltd reported an ordinary net asset value (NAV) of $772.4 million, with an NAV per share of $2.37 and a market capitalization of $691.9 million. The company has achieved a 127.6% growth in ordinary NAV per share since admission and a 103.9% total shareholder return since admission. Recent developments include the acquisition of RAPT Therapeutics by GSK, with the acquisition price representing a 65% premium to RAPT's closing share price on 19 January 2026. The company is managed by RTW Investments, LP, a seasoned healthcare investment firm.

Get the full list of 54,000+ investors

RTW Biotech Opportunities Ltd and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about RTW Biotech Opportunities Ltd

What sectors does RTW Biotech Opportunities Ltd invest in?

RTW Biotech Opportunities Ltd invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology. RTW Biotech Opportunities Ltd is listed as a mutual fund in the ConnectSafely investor database.

What stage does RTW Biotech Opportunities Ltd invest at?

RTW Biotech Opportunities Ltd backs companies at Early Stage, Growth, Late Stage and Pre-IPO, writing cheques of 5M - 50M.

Which regions does RTW Biotech Opportunities Ltd invest in?

RTW Biotech Opportunities Ltd invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.

Last updated · Source: ConnectSafely investor database